Saltar al contenido
Artículos científicos

Effectiveness of an Inactivated SARS-CoV-2 Vaccine in Chile

  • Autores: Eduardo Undurraga · Alejandro Jara · Ph.D. · ¡ Cecilia González · M.D. · Fabio Paredes · M.Sc. · Tomás Fontecilla · M.Sc. · Gonzalo Jara · B.S.E. · Alejandra Pizarro · M.D. · Johanna Acevedo · M.S. · Katherinne Leo · B.S.E. · Francisco Leon · M.B.A. · Carlos Sans · B.S.E. · Paulina Leighton · B.S.E. · et al.
  • Año: 2021

Mass vaccination campaigns to prevent coronavirus disease 2019 (Covid-19) are occurring in many countries; estimates of vaccine effectiveness are urgently needed to support decision making. A countrywide mass vaccination campaign with the use of an inactivated severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine (CoronaVac) was conducted in Chile starting on February 2, 2021.

Ver publicación completa